An independent panel of advisers to the Food and Drug Administration overwhelmingly recommended that the agency authorize Moderna’s Covid-19 vaccine for emergency use on Thursday, bringing the United States one step closer to adding a second vaccine to its toolkit in fighting the pandemic.
Members of the Vaccines and Related Biological Products Advisory Committee voted 20 to 0 in favor of recommending authorization, with one abstention.
